How do I contact Rogier Rooswinkel?

Rogier Rooswinkel, Partner at Forbion, can be reached by email. The verified email address is listed on this page.

What is Rogier Rooswinkel's email address?

Rogier Rooswinkel's email address uses the forbion.com domain (shown as *****@forbion.com until revealed).

What does Rogier Rooswinkel invest in?

Rogier Rooswinkel backs Health tech companies at Series A and Seed, typically writing €92k–€4.6M cheques.

How do I cold email Rogier Rooswinkel?

Rogier Rooswinkel backs Health tech companies at Series A and Seed, writing €92k–€4.6M cheques. A concise cold email that leads with relevant traction and one specific ask, sent to the verified address on this page, is the most direct way to reach Rogier.

Where is Rogier Rooswinkel based?

Rogier Rooswinkel is based in Amsterdam, Netherlands and works at Forbion.

Rogier Rooswinkel Email & Contact Information

Partner @ Forbion

Show Rogier's email

Rogier Rooswinkel Location

Amsterdam, Netherlands

Rogier Rooswinkel Investing

Partner at Forbion

Stages: Series A, Seed
Sectors: Health tech
Cheque size: €92k–€4.6M
Freshness: Verified 1mo ago

Rogier Rooswinkel Summary

Rogier Rooswinkel, based in Amsterdam, Netherlands, is a Partner at Forbion. Rogier Rooswinkel invests in Health tech at Series A and Seed, writing €92k–€4.6M cheques. Rogier Rooswinkel's verified email and contact details are available on Mintround.

How to cold email Rogier Rooswinkel

Rogier Rooswinkel, Forbion in Amsterdam, Netherlands, backs Health tech companies at Series A and Seed, writing €92k–€4.6M cheques. Here's how to get a reply when you cold email Rogier:

Subject line: name your company and one metric that matters to Health tech, not “quick chat”.
First line: your strongest traction, the real numbers, not adjectives.
One ask: a 20-minute call with a date range. Keep it under 150 words.
Send it to Rogier's verified address below. No warm intro required.

Show Rogier's email

Notable investments

Granite BioSeries B · $70M · 2025
LOQUS23 THERAPEUTICSSeries A · $46M · 2024
Pheon TherapeuticsSeries B · $120M · 2024
Tessellate BIOSeed · $8M · 2023
CatalYmSeries C · $52M · 2022
Amphista TherapeuticsSeries B · $53M · 2021

Frequently co-invests with

Florian MüllershausenNovartis Venture Fund2×Jonathan TobinBrandon Capital Partners2×Colleen CuffaroCanaan PartnersDaniela Couto (BGV (BioGeneration Ventures))Jon EdwardsRed Tree Venture CapitalMarianne UtengNovartis Venture FundMichael GladstoneAtlas VentureNathalie WeitemeyerBayern KapitalOscar Slotboom (BGV (BioGeneration Ventures))Raj ParekhAdvent Life SciencesSatish JindalAdvent Life Sciences

Rogier Rooswinkel's colleagues at Forbion

Sander SlootwegManaging Partner, Forbion

Wouter JoustraGeneral Partner, Forbion

Antoine Boulanger PietteAssociate, Forbion

Audrey CacalySenior Associate, Forbion

Dmitrij HristodorovPartner, Forbion

Dirk KerstenGeneral Partner, Forbion

Geert-Jan MulderManaging Partner, Forbion

Holger ReithingerGeneral Partner, Forbion

Jasper BosGeneral Partner, Forbion

Marco BoorsmaGeneral Partner, Forbion

Martien van OschManaging Partner, Forbion

Nanna LuneborgGeneral Partner, Forbion

See all 13 at Forbion →

Similar investors

Diede BrunenSenior Associate, BGV (BioGeneration Ventures)

Audrey CacalySenior Associate, Forbion

Robin van BoxselPartner, FORWARD.one

Clement SalqueAnalyst, Bioqube Ventures